ACA ARCOSA INC revenue, earnings and financials

For the quarter ended June 30, 2026, ARCOSA INC reported revenue of $659M (up 1.7% from a year earlier), net income of $329M and diluted EPS of $6.67; over the last four quarters revenue was $2.92B and net income $491M; for the fiscal year ended December 2025 revenue was $2.88B, up 12.2% on the year before.

ACA annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $2.88B, gross profit $647M, operating income $342M, net income $208M (margin 7.2%), EPS $4.24
• Fiscal year ended Dec 2024: revenue $2.57B, gross profit $515M, operating income $198M, net income $93.7M (margin 3.6%), EPS $1.91
• Fiscal year ended Dec 2023: revenue $2.31B, gross profit $444M, operating income $217M, net income $159M (margin 6.9%), EPS $3.26
• Fiscal year ended Dec 2022: revenue $2.24B, gross profit n/a, operating income $349M, net income $246M (margin 11.0%), EPS $5.05
• Fiscal year ended Dec 2021: revenue $2.04B, gross profit n/a, operating income $107M, net income $69.6M (margin 3.4%), EPS $1.42

ACA quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $659M (up 1.7% year over year), net income $329M, EPS $6.67
• Quarter ended Mar 31, 2026: revenue $572M (up 4.4% year over year), net income $37.8M, EPS $0.77
• Quarter ended Dec 31, 2025 (from the annual report): revenue $891M (up 33.7% year over year), net income $52.1M, EPS $1.06
• Quarter ended Sep 30, 2025: revenue $798M (up 24.6% year over year), net income $73.0M, EPS $1.48
• Quarter ended Jun 30, 2025: revenue $648M (down 2.6% year over year), net income $59.7M, EPS $1.22
• Quarter ended Mar 31, 2025: revenue $548M (down 8.5% year over year), net income $23.6M, EPS $0.48
• Quarter ended Dec 31, 2024 (from the annual report): revenue $666M (up 14.4% year over year), net income −$7.70M, EPS −$0.16
• Quarter ended Sep 30, 2024: revenue $640M (up 8.2% year over year), net income $16.6M, EPS $0.34
• Quarter ended Jun 30, 2024: revenue $665M (up 13.7% year over year), net income $45.6M, EPS $0.93
• Quarter ended Mar 31, 2024: revenue $599M (up 9.0% year over year), net income $39.2M, EPS $0.80
• Quarter ended Dec 31, 2023 (from the annual report): revenue $582M (up 16.4% year over year), net income $27.1M, EPS $0.56
• Quarter ended Sep 30, 2023: revenue $592M (down 2.0% year over year), net income $35.5M, EPS $0.72
• Quarter ended Jun 30, 2023: revenue $585M (down 3.0% year over year), net income $40.9M, EPS $0.84
• Quarter ended Mar 31, 2023: revenue $549M (up 2.5% year over year), net income $55.7M, EPS $1.14
• Quarter ended Dec 31, 2022 (from the annual report): revenue $500M (down 4.1% year over year), net income $155M, EPS $3.19
• Quarter ended Sep 30, 2022: revenue $604M (up 8.0% year over year), net income $32.0M, EPS $0.66
• Quarter ended Jun 30, 2022: revenue $603M (up 17.0% year over year), net income $39.0M, EPS $0.79
• Quarter ended Mar 31, 2022: revenue $536M (up 21.7% year over year), net income $20.2M, EPS $0.41
• Quarter ended Dec 31, 2021 (from the annual report): revenue $522M, net income $9.20M, EPS $0.18
• Quarter ended Sep 30, 2021: revenue $559M, net income $23.7M, EPS $0.49

ACA cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $341M, share buybacks $0, dividends $0.20 per share
• Fiscal year ended Dec 2024: operating cash flow $502M, share buybacks $0, dividends $0.20 per share
• Fiscal year ended Dec 2023: operating cash flow $261M, share buybacks $13.8M, dividends $0.20 per share
• Fiscal year ended Dec 2022: operating cash flow $174M, share buybacks $15.0M, dividends $0.20 per share
• Fiscal year ended Dec 2021: operating cash flow $167M, share buybacks $9.40M, dividends $0.20 per share

ACA balance sheet

• Jun 30, 2026: cash $432M, total assets $5.30B, total liabilities $2.32B, shareholders' equity $2.98B
• Mar 31, 2026: cash $153M, total assets $5.00B, total liabilities $2.35B, shareholders' equity $2.65B
• Dec 31, 2025: cash $215M, total assets $4.99B, total liabilities $2.34B, shareholders' equity $2.64B
• Sep 30, 2025: cash $220M, total assets $5.05B, total liabilities $2.47B, shareholders' equity $2.58B
• Jun 30, 2025: cash $190M, total assets $5.01B, total liabilities $2.50B, shareholders' equity $2.51B
• Mar 31, 2025: cash $168M, total assets $4.93B, total liabilities $2.48B, shareholders' equity $2.45B
• Dec 31, 2024: cash $187M, total assets $4.92B, total liabilities $2.49B, shareholders' equity $2.43B
• Sep 30, 2024: cash $757M, total assets $4.36B, total liabilities $1.92B, shareholders' equity $2.43B

What is ACA's revenue?

ARCOSA INC reported $2.92B of revenue over its last four quarters, through June 30, 2026.

Is ACA profitable?

Yes. ARCOSA INC earned $491M over the last four quarters.

What is ACA's EPS?

Diluted earnings per share over the last four quarters were $9.98; $6.67 in the latest quarter.

Does ACA pay a dividend?

ARCOSA INC paid $0.20 per share in dividends in the fiscal year ended December 2025.

ACA ownership and insider trades · All stocks